|
ZNF557 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4746000000242E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76735999999345E-05 |
| Normal-vs-Stage2 |
7.805000E-04 |
| Normal-vs-Stage3 |
7.5378999997433E-07 |
| Normal-vs-Stage4 |
3.27119999976588E-07 |
| Stage1-vs-Stage2 |
3.986600E-01 |
| Stage1-vs-Stage3 |
1.576760E-01 |
| Stage1-vs-Stage4 |
4.539600E-02 |
| Stage2-vs-Stage3 |
6.970200E-02 |
| Stage2-vs-Stage4 |
2.077800E-02 |
| Stage3-vs-Stage4 |
3.687600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77430000003476E-06 |
| Normal-vs-AfricanAmerican |
3.241900E-02 |
| Normal-vs-Asian |
5.60629999999396E-05 |
| Caucasian-vs-AfricanAmerican |
3.669200E-01 |
| Caucasian-vs-Asian |
7.672800E-01 |
| AfricanAmerican-vs-Asian |
4.800600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01659999999881E-05 |
| Normal-vs-Female |
2.30420000002507E-06 |
| Male-vs-Female |
7.347800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74598999999054E-05 |
| Normal-vs-Age(41-60Yrs) |
2.34060000003922E-06 |
| Normal-vs-Age(61-80Yrs) |
3.62059999999831E-05 |
| Normal-vs-Age(81-100Yrs) |
1.358240E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.925400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.347800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.389000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.203000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.493000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.035200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.18199999999702E-05 |
| Classical-VS-Follicular |
4.428000E-01 |
| Classical-VS-Other |
2.340200E-01 |
| Classical-VS-Normal |
5.60199999999345E-05 |
| Tall-VS-Follicular |
2.218200E-03 |
| Tall-VS-Other |
5.216000E-01 |
| Tall-VS-Normal |
2.75959999296305E-09 |
| Follicular-VS-Other |
4.057000E-01 |
| Follicular-VS-Normal |
4.02590000000425E-05 |
| Other-VS-Normal |
1.567590E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.46329999999251E-05 |
| Normal-vs-N1 |
1.74460000001986E-07 |
| N0-vs-N1 |
9.395900E-03 |
|
|
